License Agreement
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor
SeraNovo
PR-M10-19-NI-046Oct 30, 2019
Strategic Collaboration
Evotec and Carna Biosciences Collaborate on Indigo Platform
Evotec
PR-M05-18-NI-047May 11, 2018